Methods and systems for predicting drug-response

作者: Nahid Razi

DOI:

关键词:

摘要: Disclosed herein are methods and systems for determining whether a cell is resistant to one or more drugs. Also, disclosed monitoring the treatment of cancer patient determine cancerous cells being treated treatment. Further, predicting responsiveness drug. rate efficacy chemotherapeutic drug on cancerous, neoplastic damaged

参考文章(28)
Azita Alavi, John S. Axford, The pivotal nature of sugars in normal physiology and disease Wiener Medizinische Wochenschrift. ,vol. 156, pp. 19- 33 ,(2006) , 10.1007/S10354-005-0247-4
Suzannah A. Williams, Pamela Stanley, Roles for N- and O-glycans in early mouse development. Advances in Experimental Medicine and Biology. ,vol. 705, pp. 397- 410 ,(2011) , 10.1007/978-1-4419-7877-6_20
Massimo Cristofanilli, Ola Blixt, Margaret Huflejt, Detection, prevention and treatment of ovarian cancer ,(2007)
Daniel R. Rhodes, Classification of cancers ,(2010)
Shinji Go, Misato Yoshikawa, Jin-ichi Inokuchi, Glycoconjugates in the mammalian auditory system Journal of Neurochemistry. ,vol. 116, pp. 756- 763 ,(2011) , 10.1111/J.1471-4159.2010.07099.X
Steven B. Levery, Ulla Mandel-Clausen, Edward Nudelman, Sen-itiroh Hakomori, Yoshiyuki Tsuji, Shinzo Isojima, Tokio Kaizu, Monoclonal antibody nuh2 capable of inactivating motility of human sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen ,(1988)
Zdenka Sulová, Danica Mislovičová, Lenka Gibalová, Zuzana Vajčnerová, Eva Poláková, Branislav Uhrík, Lucia Tylková, Annamária Kovárová, Ján Sedlák, Albert Breier, Vincristine-induced overexpression of P-glycoprotein in L1210 cells is associated with remodeling of cell surface saccharides. Journal of Proteome Research. ,vol. 8, pp. 513- 520 ,(2009) , 10.1021/PR8007094
Serenus Hua, Hyun Joo An, Sureyya Ozcan, Grace S. Ro, Stephanie Soares, Ralph DeVere-White, Carlito B. Lebrilla, Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers Analyst. ,vol. 136, pp. 3663- 3671 ,(2011) , 10.1039/C1AN15093F